BioCentury

7:00 AM GMT, Jun 29, 2015
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

Swallowing large molecules

Researchers have been working on oral delivery of peptides and antibodies for decades with limited success. Rani Therapeutics LLC is taking a different approach, with an orally delivered, pH-activated capsule that uses sugar needles to inject large molecule therapeutics into the muscle of the intestine.

Chairman and CEO Mir Imran said most attempts to create oral formulations of large molecules have focused either on blocking degrading enzymes in the GI tract, or on modifying drug molecules so

Read the full 784 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.